Gambaran Ekspresi Cluster of Differentiation 44 (CD44) Pada Meningothelial Meningioma di RSUD Provinsi Nusa Tenggara Barat

Authors

  • Hilda Santosa Fakultas Kedokteran Universitas Islam Al-Azhar Mataram, Nusa Tenggara Barat
  • Cheryl Nini Fakultas Kedokteran Universitas Islam Al-Azhar Mataram, Nusa Tenggara Barat
  • Sabariah Sabariah Fakultas Kedokteran Universitas Islam Al-Azhar Mataram, Nusa Tenggara Barat
  • Muhammad Astro Perdana Fakultas Kedokteran Universitas Islam Al-Azhar Mataram, Nusa Tenggara Barat

DOI:

https://doi.org/10.29303/jstl.v10i1.610

Keywords:

meningothelial meningioma, CD44, tumor cells

Abstract

Meningiomas are mostly benign tumors that grow slowly and are very common compared to other intracranial tumors with the most frequent subtype being meningothelial meningioma. Cluster of differentiation 44 is a cell surface glycoprotein that has an important role in cellular adhesion, migration, angiogenesis, proliferation and inflammation. This study aims to examine the description of CD44 expression in meningothelial meningioma at West Nusa Tenggara Provincial Hospital. This study is a quantitative descriptive analysis research, sample 27 cases of meningothelial meningioma CD44 expression was evaluated by immunohistochemistry. Quantitative descriptive analysis to determine the percentage of the study sample. The results obtained were 19 (70.40%) age range 41-50 years. CD44 expression in meningothelial meningioma was found to be mild in 3 (11.10%), moderate expression in 5 (18.50%) and strong in 19 (70.40%). In conclusion, most of the percentages of tumor cells that were smeared were in the severe category (percentage value of more than 50 percent).

References

Abd Elhakeem, A.A.E., Essa, A.A., Soliman, R.K. & Hamdan, A.R.K. 2022. Novel evaluation of the expression patterns CD44 and MMP9 proteins in intracranial meningiomas and their relationship to the overall survival. Egyptian Journal of Neurosurgery, 37(1).

Jahangir Moini MD, MPH, Nicholas G. Avgeropoulos MD, Mohtashem Samsam MD, PhD. Epidemiology of Brain and Spinal Tumors. Chapter 12 – Meningioma. Copyright © 2021 Elsevier Inc. All rights reserved., Pages 215-231, https://doi.org/10.1016/B978-0-12-821736-8.00015-7

Lee, Y.S. & Lee, Y.S. 2020. Molecular characteristics of meningiomas. Journal of Pathology and Translational Medicine.

Lim YS, Kim MK, Park BJ, Kim TS, Lim YJ. Long term clinical outcomes of malignant meningiomas. Brain Tumor Res Treat. 2013 Oct;1(2):85-90. [PMC free article] [PubMed]

Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012-2016. Neuro Oncol. 2019 Nov 01;21(Suppl 5): v1-v100. [PMC free article] [PubMed]

Wiemels J, Wrensch M, Claus EB. Epidemiology and etiology of meningioma. J Neurooncol. 2010 Sep;99(3):307-14. [PMC free article] [PubMed]Available from: https://ojs.unud.ac.id/index.php/eum

Downloads

Published

2024-03-30